McCubrey JA - Search Results

1

Nuclear inositide signaling and cell cycle.

Ratti S, Ramazzotti G, Faenza I, Fiume R, Mongiorgi S, Billi AM, McCubrey JA, Suh PG, Manzoli L, Cocco L, Follo MY. Ratti S, et al. Among authors: mccubrey ja. Adv Biol Regul. 2018 Jan;67:1-6. doi: 10.1016/j.jbior.2017.10.008. Epub 2017 Oct 23. Adv Biol Regul. 2018. PMID: 29102395 Review.

2

Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs.

Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA, Franklin RA, Oberhaus SM, Steelman LS, McCubrey JA. Blalock WL, et al. Among authors: mccubrey ja. Leukemia. 1999 Aug;13(8):1109-66. doi: 10.1038/sj.leu.2401493. Leukemia. 1999. PMID: 10450743 Review.

3

Raf-induced cell cycle progression in human TF-1 hematopoietic cells.

Chang F, Steelman LS, McCubrey JA. Chang F, et al. Among authors: mccubrey ja. Cell Cycle. 2002 May-Jun;1(3):220-6. Cell Cycle. 2002. PMID: 12429936

4

EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review).

Navolanic PM, Steelman LS, McCubrey JA. Navolanic PM, et al. Among authors: mccubrey ja. Int J Oncol. 2003 Feb;22(2):237-52. Int J Oncol. 2003. PMID: 12527919 Review.

5

Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).

Chang F, Steelman LS, Shelton JG, Lee JT, Navolanic PM, Blalock WL, Franklin R, McCubrey JA. Chang F, et al. Among authors: mccubrey ja. Int J Oncol. 2003 Mar;22(3):469-80. Int J Oncol. 2003. PMID: 12579299 Review.

6

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.

Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA. Chang F, et al. Among authors: mccubrey ja. Leukemia. 2003 Mar;17(3):590-603. doi: 10.1038/sj.leu.2402824. Leukemia. 2003. PMID: 12646949 Review.

7

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.

Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA. Steelman LS, et al. Among authors: mccubrey ja. Leukemia. 2004 Feb;18(2):189-218. doi: 10.1038/sj.leu.2403241. Leukemia. 2004. PMID: 14737178 Review.

8

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M. McCubrey JA, et al. Adv Enzyme Regul. 2006;46:249-79. doi: 10.1016/j.advenzreg.2006.01.004. Epub 2006 Jul 18. Adv Enzyme Regul. 2006. PMID: 16854453

9

Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.

McCubrey JA, Steelman LS, Franklin RA, Abrams SL, Chappell WH, Wong EW, Lehmann BD, Terrian DM, Basecke J, Stivala F, Libra M, Evangelisti C, Martelli AM. McCubrey JA, et al. Adv Enzyme Regul. 2007;47:64-103. doi: 10.1016/j.advenzreg.2006.12.013. Epub 2007 Mar 26. Adv Enzyme Regul. 2007. PMID: 17382374 Free PMC article. No abstract available.

10

Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside.

Martelli AM, Tazzari PL, Evangelisti C, Chiarini F, Blalock WL, Billi AM, Manzoli L, McCubrey JA, Cocco L. Martelli AM, et al. Among authors: mccubrey ja. Curr Med Chem. 2007;14(19):2009-23. doi: 10.2174/092986707781368423. Curr Med Chem. 2007. PMID: 17691943 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

428 results

Search Page